Bleomycin
- Product NDC
- 69097-364
- 11-digit product format
- 690970364
- Labeler code
- 69097
- Product ID
- 69097-364_0014ce7e-f3e5-467c-a1a4-6bf8c2aefd3c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bleomycin
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Cipla USA Inc.
- Application
- ANDA209439
- Marketing category
- ANDA
- Marketing start
- 2019-03-11
- Marketing end
- 0000-00-00
- Substance
- BLEOMYCIN SULFATE
- Active strength
- 15 [USP'U]/1
- Pharmacologic classes
- Cytoprotective Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-364 | BLEOMYCIN INJECTION [CIPLA USA INC.] | 1 | Legacy NDC | 20190402_497e462a-a295-4db1-9002-d2633efbd676.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-364-36 | 69097036436 | 1 VIAL in 1 CARTON (69097-364-36) > 1 INJECTION in 1 VIAL | 1 vial | 2019-03-11 | 0000-00-00 | No | No | Current |